Financial Management Professionals’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16
Closed -$3K 949
2023
Q1
$3K Buy
+16
New +$3.63K ﹤0.01% 747
2022
Q1
Sell
-201
Closed -$76K 1035
2021
Q4
$76K Sell
201
-3
-1% -$1.17K 0.02% 207
2021
Q3
$84K Buy
204
+12
+6% +$4.98K 0.02% 175
2021
Q2
$71K Sell
192
-62
-24% -$20.7K 0.02% 198
2021
Q1
$74K Buy
254
+7
+3% +$1.95K 0.02% 178
2020
Q4
$62K Buy
247
+8
+3% +$1.91K 0.02% 195
2020
Q3
$54K Hold
239
0.02% 192
2020
Q2
$42K Buy
+239
New +$38.1K 0.01% 227

Other funds holding CRL

Financial Management Professionals's CRL Position: Q2 2023 in Review

Financial Management Professionals sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 16 shares — an estimated $3K sold.

Financial Management Professionals first reported a position in CRL in Q2 2020 and held it in 8 quarters. The position peaked at $84K in Q3 2021. 612 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Financial Management Professionals reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • Financial Management Professionals sold 16 Charles River Laboratories shares in Q2 2023, an estimated $3K.
  • Financial Management Professionals first reported a position in Charles River Laboratories in Q2 2020 and held it in 8 quarters.
  • Financial Management Professionals's Charles River Laboratories position peaked at $84K in Q3 2021.
  • 612 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Financial Management Professionals's 13F filing for Q2 2023, filed 10 Jul 2023.